Measuring Human Lipid Metabolism Using Deuterium Labeling: In Vivo and In Vitro Protocols.

[1]  L. Hodson,et al.  In vitro cellular models of human hepatic fatty acid metabolism: differences between Huh7 and HepG2 cell lines in human and fetal bovine culturing serum , 2017, Physiological reports.

[2]  S. Neubauer,et al.  Fasting Plasma Insulin Concentrations Are Associated With Changes in Hepatic Fatty Acid Synthesis and Partitioning Prior to Changes in Liver Fat Content in Healthy Adults , 2016, Diabetes.

[3]  S. Neubauer,et al.  Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men. , 2015, The Journal of clinical endocrinology and metabolism.

[4]  J. Borén,et al.  De novo lipogenesis in metabolic homeostasis: More friend than foe? , 2015, Molecular metabolism.

[5]  J. Browning,et al.  Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. , 2014, Gastroenterology.

[6]  E. Ryan,et al.  Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes , 2009, Diabetologia.

[7]  S. O’Rahilly,et al.  Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. , 2009, The Journal of clinical investigation.

[8]  E. Parks,et al.  Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. , 2006, The Journal of clinical endocrinology and metabolism.

[9]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[10]  M. Beylot,et al.  Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. , 2003, Diabetes & metabolism.

[11]  S. Wootton,et al.  A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction* , 2000, British Journal of Nutrition.

[12]  M. Casu,et al.  N.m.r. lipid profiles of cells, tissues and body fluids. Neutral, non-acidic and acidic phospholipid analysis of Bond Elut chromatographic fractions. , 1993, The Biochemical journal.

[13]  R Schoenheimer,et al.  The Investigation of Intermediary Metabolism with the Aid of Heavy Hydrogen: Harvey Lecture, January 21, 1937. , 1937, Bulletin of the New York Academy of Medicine.

[14]  D. Rittenberg,et al.  DEUTERIUM AS AN INDICATOR IN THE STUDY OF INTERMEDIARY METABOLISM. , 1935, Science.

[15]  E. Parks,et al.  Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis. , 2015, The American journal of clinical nutrition.

[16]  E. Parks,et al.  Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. , 2005, The American journal of clinical nutrition.

[17]  M. Beylot,et al.  Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: use of simple gas chromatographic/mass spectrometric techniques. , 1997, Journal of mass spectrometry : JMS.

[18]  M. Hellerstein,et al.  Regulation of hepatic de novo lipogenesis in humans. , 1996, Annual review of nutrition.